Join to View Full Profile
Seattle Cancer Care Alliance825 Eastlake Avenue EastSeattle, WA 98109
Phone+1 206-288-1012
Dr. Abkowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rutgers Health/Newark Beth Israel Medical CenterResidency, Internal Medicine, 1977 - 1980
Harvard Medical SchoolClass of 1977, MD
Certifications & Licensure
WA State Medical License 1980 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1992
Publications & Presentations
PubMed
- A proposed path to explaining the unexplained anemia of aging.Nahed El Kassar, Amy E DeZern, Janis Abkowitz, Andrew Artz, Isabel Beerman
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2026-01-02 - 40 citationsGAGE-seq concurrently profiles multiscale 3D genome organization and gene expression in single cells.Tianming Zhou, Ruochi Zhang, Deyong Jia, Raymond T Doty, Adam D Munday
Nature Genetics. 2024-08-01 - 10 citationsDose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial.Noam E Kopmar, Kim Quach, Ted A Gooley, Christen H Martino, Sindhu Cherian
JAMA Oncology. 2024-07-01
Abstracts/Posters
- Myelodysplastic Syndrome with Excess Blasts and Secondary Acute Myeloid Leukemia: Same Disease with Different Blast CountJanis L. Abkowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Phase 1 Trial of Cladribine, High-Dose Cytarabine, G-CSF, and Dose-Escalated Mitoxantrone (CLAG-M) Plus Gemtuzumab Ozogamicin in Adults with Newly-Diagnosed Acute Myel...Janis L. Abkowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Deletions of 5q Promote Genome Instability in TP53-Mutant MDS/AMLJanis L. Abkowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Remembering Elihu “Eli” Estey, Thomas Waldmann, and MoreNovember 1st, 2021
Alveolar Levels of Immuno-Inflammatory Mediators in Diffuse Alveolar Hemorrhage After Allogeneic TransplantApril 18th, 2018- This Seattle Man Survived Leukemia Thanks to a German Blood Marrow Donor. Now They're FriendsNovember 16th, 2023
Grant Support
- Hematology TrainingUNIVERSITY OF WASHINGTON1975–2030
- Hematology TrainingUNIVERSITY OF WASHINGTON1975–2030
- Deciphering the molecular mechanism of ineffective erythropoiesis in MDS-5qUNIVERSITY OF WASHINGTON2023–2025
- Heme synthesis, use and trafficking during erythropoiesisUNIVERSITY OF WASHINGTON1986–2025
- Heme Trafficking And Its Impact On Systemic Iron HomeostasisNational Institute Of Diabetes And Digestive And Kidney Diseases2011–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
